All reasonable measures on tobacco control adopted by the WHO (World Health Organization) in this direction, do not provide a significant reduction in growth in the number of diseases caused by smoking. According to all forecasts in the next decade the number of such diseases will tend to increase. Due to the fact that this problem is more acute than propose a simple innovative solution to this problem at the moment I can say only that the technology is applicable to the tobacco industry and is based on the inactivation of entering the body smoking harmful substances on a biological level. When implementing the proposed technology achieves results, expressed as the minimization of negative effects on the body of toxic products contained in the stream of tobacco smoke, and as a result significantly reduces the risk of occurrence and development of diseases caused by these toxins. The complex effect on the body provides effective protection primarily from cancer, as well as cardiovascular diseases, musculoskeletal and endocrine systems. What is achieved by embedding in each packet of tobacco products, blister packs with pills, granules Farm. inactivator. The composition of granules is a balanced set of biologically active substances intended to minimize the harmful effects of toxic products entering the body from smoking.

 

 The proposed technology is directly related to the activities of WHO. At the moment the Russian Patent Office filed an application for an invention, but the review may take anywhere from 3 to 5 years. Prepare the same application for filing with the U.S. Patent Office. However, the rapid introduction of this technology will in the next decade to save millions of lives and direct participation of WHO can really accelerate the introduction of this technology. At first glance, the solution is very simple, but expert in the field of medicine will be able to realistically assess the effectiveness of early implementation of this technology to significantly reduce the number of fatal diseases caused by smoking.

 

Implementation of the proposed technology in a commercial way has great prospects, as it involves the tobacco industry and medicine. The commercial benefits of universal vaccination against swine flu, it is nothing. Recognition of the effectiveness of this technology luminaries of medicine is inevitable, because the basis of this technology are really working modern medical technology.

 

Looking for people with experience in the innovation sector can really accelerate the introduction of this technology. s.tchernoff2011 @ yandex.ru